|
Indications and Dosage
Oral
Hypertension Adult: As sulfate: 12.5 mg bid. Max: 50 mg bid.
|
|
Renal Impairment
Dosage adjustments may be needed.
|
|
Hepatic Impairment
Dosage adjustments may be needed.
|
|
Contraindications
Severe tachycardia, dissecting aortic aneurysm, heart failure with high cardiac output, cor pulmonale, MI due to mechanical obstruction, idiopathic SLE and related disorders. Porphyria. 1st 2 trimesters during pregnancy.
|
|
Special Precautions
Ischaemic heart disaease, MI, cerebrovascular disorders, renal or hepatic impairment. Monitor for postural hypotension and tachycardia during initial therapy if given to patients with heart failure. Gradual withdrawal is advisable.
|
|
Adverse Reactions
Tachycardia, palpitations, angina pectoris, severe headache, GI disturbances, flushing, dizziness, nasal congestion, postural hypotension, fluid retention with oedema and wt gain, conjunctivitis, lachrymation, tremor, peripheral neuropathy with numbness and tingling of extremities, muscle cramps, hepatotoxicity, blood dyscrasias, haemolytic anaemia, difficulty in urinating, glomerulonephritis, constipation, paralytic ileus, depression, anxiety, hypersensitivity reactions, eosinophilia. A condition resembling SLE with prolonged use of large doses.
|
|
Drug Interactions
Agents with hypotensive action, diazoxide, thiazide diuretics.
|
|
Action
Description:
Mechanism of Action: Dihydralazine is a direct-acting vasodilator which acts predominantly on the arterioles. It reduces BP and peripheral resistance thus increasing cardiac output. It also tends to improve renal and cerebral blood flow and its effect on diastolic pressure is more marked than on systolic pressure. |
|
MIMS Class
|
Sign Out
